Document is current
Any future updates will be listed below
-
Authors
Kamada, Ayaka
Hirose, Takuo https://orcid.org/0000-0002-8761-3779
Sato, Shigemitsu
Takahashi, Chika
Kaburaki, Takahito
Sato, Kaori
Ishikawa, Risa
Endo, Akari
Ito, Hiroki
Oba-Yabana, Ikuko
Nakamura, Hannah
Matsuyama, Makoto
Mori, Takefumi
-
Funding
Funding for this research was provided by:
Takeda Medical Research Foundation
Mochida Memorial Foundation for Medical and Pharmaceutical Research (2022研4-47)
Japan Society for the Promotion of Science (JP20K08612)
Japan Society for the Promotion of Science (JP23K07690)
Japan Society for the Promotion of Science (JP24K10956)
Miyagi Kidney Foundation
- License Information
-
More Information
Article History
Received: 16 July 2024
Accepted: 28 February 2025
First Online: 18 March 2025
Declarations
:
: The Division of Integrative Renal Replacement Therapy (T.H., S.S., C.T., and T.M.) was financially supported by JMS Co. Ltd., Terumo Corporation, and Southern TOHOKU Hospital Group (STHG). All the other authors declared no competing interests.
: All procedures involving animals were performed in accordance with the ethical standards of the institution where the studies were conducted. This study was approved by the Tohoku Medical and Pharmaceutical University Animal Experiment Committee (approval nos. A20015, A21011-cn, A22039-cn, A23033-cn, and A24037-cn).
: This article does not contain any studies with human participants performed by any of the authors.
